Pedro Nacarino-Oliva

Oviedo, AS, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Correction: Prevalence and incidence of multiple sclerosis in healthcare district IV of Asturias, Spain.

Correction: Prevalence and incidence of multiple sclerosis in healthcare district IV of Asturias, Spain.

Journal: BMC neurology

Published: March 23, 2025

Prevalence and incidence of multiple sclerosis in healthcare district IV of Asturias, Spain.

Prevalence and incidence of multiple sclerosis in healthcare district IV of Asturias, Spain.

Journal: BMC neurology

Published: November 07, 2024

Practical tool to identify Spasticity-Plus Syndrome amongst patients with multiple sclerosis. Algorithm development based on a conjoint analysis.

Practical tool to identify Spasticity-Plus Syndrome amongst patients with multiple sclerosis. Algorithm development based on a conjoint analysis.

Journal: Frontiers in neurology

Published: January 16, 2024

Crohn's disease induced by ocrelizumab in a patient with multiple sclerosis.

Crohn's disease induced by ocrelizumab in a patient with multiple sclerosis.

Journal: Revista espanola de enfermedades digestivas

Published: September 30, 2022

Clinical characterization and outcomes of 85 patients with neurosarcoidosis.

Clinical characterization and outcomes of 85 patients with neurosarcoidosis.

Journal: Scientific reports

Published: September 04, 2020

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

Journal: Neurologia

Published: September 27, 2019

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

Journal: Neurologia

Published: September 27, 2019

Appraisal of cerebral atrophy in multiple sclerosis by means of the corpus callosum index. Reply

Appraisal of cerebral atrophy in multiple sclerosis by means of the corpus callosum index. Reply

Journal: Revista de neurologia

Published: March 12, 2019

Appraisal of cerebral atrophy in multiple sclerosis by means of the corpus callosum index

Appraisal of cerebral atrophy in multiple sclerosis by means of the corpus callosum index

Journal: Revista de neurologia

Published: November 29, 2018

Quantification of brain atrophy in multiple sclerosis using two-dimensional measurements.

Quantification of brain atrophy in multiple sclerosis using two-dimensional measurements.

Journal: Neurologia

Published: April 05, 2018

Melanoma, eruptive naevi and natalizumab: Causal relation or coincidence?

Melanoma, eruptive naevi and natalizumab: Causal relation or coincidence?

Journal: The Australasian journal of dermatology

Published: September 20, 2017

Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (II).

Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (II).

Journal: Revista de neurologia

Published: July 05, 2017

Showing 1-12 of 25

Last Updated: 09/26/2026